LENZ Therapeutics, Inc. (LENZ)
3.20
-0.30
(-8.57%)
USD |
NASDAQ |
Nov 18, 16:00
3.21
+0.01
(+0.31%)
After-Hours: 20:00
LENZ Therapeutics Total Assets (Quarterly) : 209.75M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 209.75M |
| June 30, 2026 | 236.60M |
| March 31, 2026 | 272.54M |
| December 31, 2025 | 305.88M |
| September 30, 2025 | 210.70M |
| June 30, 2025 | 217.33M |
| March 31, 2025 | 201.25M |
| December 31, 2024 | 215.30M |
| September 30, 2024 | 224.01M |
| June 30, 2024 | 202.64M |
| March 31, 2024 | 217.32M |
| December 31, 2023 | 70.38M |
| Date | Value |
|---|---|
| September 30, 2023 | 266.23M |
| June 30, 2023 | 287.04M |
| March 31, 2023 | 310.00M |
| December 31, 2022 | 321.90M |
| September 30, 2022 | 334.84M |
| June 30, 2022 | 353.79M |
| March 31, 2022 | 378.61M |
| December 31, 2021 | 401.99M |
| September 30, 2021 | 416.15M |
| June 30, 2021 | 387.11M |
| March 31, 2021 | 182.91M |
| December 31, 2020 | 22.56M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| EyePoint, Inc. | 166.14M |
| Ligand Pharmaceuticals, Inc. | 2.237B |
| Bristol Myers Squibb Co. | 88.77B |
| Context Therapeutics, Inc. | 36.54M |
| Neumora Therapeutics, Inc. | 95.05M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 17.75M |
| Shareholders Equity (Quarterly) | 192.00M |
| Debt to Equity Ratio | 0.0024 |
| Current Ratio | 11.66 |
| Net Debt Paydown Yield | 0.10% |